Merit Medical Systems - 15 Year Stock Price History | MMSI
Historical daily share price chart and data for Merit Medical Systems since 2011 adjusted for splits and dividends. The latest closing stock price for Merit Medical Systems as of June 17, 2026 is 65.24.
- The all-time high Merit Medical Systems stock closing price was 110.29 on January 30, 2025.
- The Merit Medical Systems 52-week high stock price is 96.74, which is 48.3% above the current share price.
- The Merit Medical Systems 52-week low stock price is 59.74, which is 8.4% below the current share price.
- The average Merit Medical Systems stock price for the last 52 weeks is 79.90.
| Merit Medical Systems Historical Annual Stock Price Data | ||||||
|---|---|---|---|---|---|---|
| Year | Average Stock Price | Year Open | Year High | Year Low | Year Close | Annual % Change |
| 2026 | 72.2002 | 86.4500 | 93.1800 | 60.3100 | 65.2400 | -25.98% |
| 2025 | 92.3409 | 96.0700 | 110.2900 | 78.9900 | 88.1400 | -8.87% |
| 2024 | 86.8961 | 76.3800 | 105.5200 | 70.9900 | 96.7200 | 27.33% |
| 2023 | 73.2972 | 69.6000 | 85.2400 | 62.9200 | 75.9600 | 7.56% |
| 2022 | 61.3618 | 63.8200 | 74.4300 | 51.6800 | 70.6200 | 13.35% |
| 2021 | 63.5782 | 54.7600 | 73.2300 | 52.5600 | 62.3000 | 12.23% |
| 2020 | 43.2665 | 31.4600 | 58.1100 | 25.9400 | 55.5100 | 77.80% |
| 2019 | 45.6149 | 53.2000 | 62.6000 | 20.6550 | 31.2200 | -44.06% |
| 2018 | 52.9778 | 43.5500 | 65.9400 | 42.1000 | 55.8100 | 29.19% |
| 2017 | 35.9451 | 26.2000 | 45.4000 | 24.7000 | 43.2000 | 63.02% |
| 2016 | 20.9843 | 18.0600 | 26.6500 | 15.7200 | 26.5000 | 42.55% |
| 2015 | 20.4758 | 16.8800 | 25.6400 | 15.3300 | 18.5900 | 7.27% |
| 2014 | 14.1817 | 15.1900 | 17.5300 | 11.7000 | 17.3300 | 10.10% |
| 2013 | 12.9920 | 14.0200 | 16.5200 | 9.6400 | 15.7400 | 13.24% |
| 2012 | 13.4980 | 13.6100 | 15.2100 | 11.6000 | 13.9000 | 3.89% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical & Dental Supplies | $4.072B | $1.516B |
| Merit Medical Systems, Inc. provides various peripheral and cardiac intervention products to cure cardiac conditions specific to interventional cardiology and electrophysiology. The company offers products focused in five core product groups: peripheral intervention, cardiac intervention, interventional oncology and spine, cardiovascular and critical care as well as endoscopy. However, the company operates in two revenue segments: Cardiovascular and Endoscopy Devices. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| McKesson (MCK) | United States | $106.025B | 23.03 |
| Cardinal Health (CAH) | United States | $50.715B | 22.43 |
| Becton Dickinson (BDX) | United States | $43.913B | 11.10 |
| West Pharmaceutical Services (WST) | United States | $18.493B | 35.19 |
| Straumann Holding AG (SAUHY) | Switzerland | $16.902B | 0.00 |
| Cooper (COO) | United States | $13.894B | 16.52 |
| Align Technology (ALGN) | United States | $12.400B | 21.09 |
| Henry Schein (HSIC) | United States | $8.645B | 15.16 |
| DENTSPLY SIRONA (XRAY) | United States | $2.339B | 7.36 |
| STAAR Surgical (STAA) | United States | $1.309B | 0.00 |
| CONMED (CNMD) | United States | $1.107B | 7.97 |
| Pro-Dex (PDEX) | United States | $0.165B | 19.65 |
| Lifevantage (LFVN) | United States | $0.053B | 5.46 |
| Axe Compute (AGPU) | United States | $0.022B | 0.00 |